ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2022 American Transplant Congress

    High Level Cytomegalovirus Viremia in Liver Transplant Recipients: Risk Factors and Associated Outcomes

    H. L. Kleiboeker1, M. R. Jorgenson1, G. E. Leverson2, J. P. Rice3, C. M. Saddler4, J. A. Smith4, D. Al-Adra3

    1Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI, 2Department of Surgery, UW School of Medicine and Public Health, Madison, WI, 3Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Department of Medicine, Division of Infectious Diseases, University of Wisconsin School of Medicine and Public Health, Madison, WI

    *Purpose: To evaluate epidemiology, risk-factors and outcomes of high-level CMV viremia in LTX recipients.*Methods: Retrospective review of adults who received LTX between 1/1/2017-9/30/2020. Inclusion criteria…
  • 2022 American Transplant Congress

    Validation of the iBox Surrogate End Point in CNI Free, Belatacept Treated Patients (BENEFIT & BENEFIT-EXT)

    G. Divard1, O. Aubert1, M. Raynaud1, F. Vincenti2, L. Rostaing3, A. Durbach4, C. Legendre1, R. Vadanici5, A. Loupy1, -. BENEFIT & BENEFIT-EXT Investigators6

    1Paris Transplant Group, INSERM, Paris, France, 2UCSF, San Francisco, CA, 3Grenoble, Grenoble, France, 4APHP, Paris, France, 5BMS, Rueil Malmaison, France, 6BMS, New York, NY

    *Purpose: The iBox is a prognostication system for long-term kidney allograft survival, developed with mostly patients under a CNI based immunosuppression. Patients treated with a…
  • 2022 American Transplant Congress

    Bone Effect and Safety of One Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study

    C. Alfieri, M. Gandolfo, D. Cresseri, M. Campise, A. Regalia, P. Messa, G. Castellano

    Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Milano, Milano, Italy

    *Purpose: In our observational monocentric study, we evaluated the effects on femoral and lumbar bone mineral density (BMD) and on MM parameters, and the safety…
  • 2022 American Transplant Congress

    COVID-19 Infection Post-Transplant: What is the Collateral Damage to the Graft? A Case for Pre-Transplant Vaccination

    A. Fabick1, E. Overly1, V. Rao2, V. Rohan3, N. Patel1, D. DuBay3, C. Candland3, N. Pilch1

    1Department of Pharmacy, Medical University of South Carolina, Charleston, SC, 2Department of Transplant Nephrology, Medical University of South Carolina, Charleston, SC, 3Department of Transplant Surgery, Medical University of South Carolina, Charleston, SC

    *Purpose: COVID-19 produces an unpredictable immune reaction and is challenging to manage during active infection and post-infection, in kidney transplant (KTX) recipients. The first peak…
  • 2022 American Transplant Congress

    Long Term Analysis of Pediatric En-Bloc Kidney Transplantation: A Single Center Experience

    H. H. Patel1, P. Di Cocco2, J. Almario2, A. Fratti2, S. Akshelyan2, E. Benedetti2, I. Tzvetanov2, M. Spaggiari2

    1University of Missouri-Kansas City School of Medicine, Kansas City, MO, 2University of Illinois at Chicago, Chicago, IL

    *Purpose: Pediatric en-bloc kidney transplantations for adult recipients are uncommonly performed due to unique donor characteristics, the technical challenge of the operation, and potential surgical…
  • 2022 American Transplant Congress

    Outcome of Living Donor Kidney Transplant and Deceased Donor Kidney Transplant: A Retrospective Cohort Study at National Kidney and Transplant Institute

    A. B. Burog, A. Parayno

    ORGAN TRANSPLANTATION AND VASCULAR SURGERY, National Kidney And Transplant Institute, Quezon City, Philippines

    *Purpose: To compare the graft and patient survival of living and deceased donor kidney transplant and identify the factors that affect graft survival.*Methods: Retrospective cohort…
  • 2022 American Transplant Congress

    Binding Mechanisms For Donor Dc-derived Exosomes To Cross-dress Of Recipient Dc

    L. ZHANG1, X. LI1, J. LIU1, H. WEI1, C. LI1, A. HUANG2, C. ZHENG1, Q. LIU1

    1Department of Biochemistry, Southern University of Science and Technology, Shenzhen, China, 2Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    *Purpose: Our previous evidence suggests donor dendritic cell (DC)-derived exosomes cross-dress recipient DC after heart transplantation in mice. This process plays a critical role in…
  • 2022 American Transplant Congress

    Risk Factors Associated with Medium-Term Allograft and Recipient Survival: Learned from 1,587 Adults with Single Kidney Transplantation

    S. Chang1, B. Liu1, D. Du1, N. Gong2, L. Zhu1, G. Chen1, W. Zhang1, Z. Chen2

    1Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,HUST, Wuhan, China, 2Huazhong University of Science and Technology, Wuhan, China

    *Purpose: Retrospectively investigated the reason for graft failure during the perioperative period and discussed whether DGF and the high SCr level in a short time…
  • 2022 American Transplant Congress

    Long-Term Outcomes After Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant: A Matched Cohort Study

    G. Divard, C. Debiais, C. Legendre, O. Aubert, C. Lefaucheur, A. Loupy

    Paris Transplant Group, INSERM, Paris, France

    *Purpose: Conversion to belatacept after transplant seems to be safe. However, no studies have reported the long-term efficacy and safety outcomes after conversion to belatacept…
  • 2022 American Transplant Congress

    Overexpression of Human Ectonucleoside Triphosphate Diphosphohydrolase 1 (entpd1; Hcd39) Did Not Afford Significant Protection on Porcine Endothelial Cells

    R. Matheson1, B. Gonzalez Nolasco1, K. Deng1, R. Garofalo1, N. Serifis1, T. M. Coe1, C. Rhatigan1, D. Gil1, D. Cloonan1, K. Lee1, K. Hall2, M. Youd2, J. F. Markmann1, S. C. Robson3

    1Transplantation surgery research, Massachusetts General Hospital, Boston, MA, 2eGenesis Bio, Cambridge, MA, 3Beth Israel Deaconess Medical Center, Boston, MA

    *Purpose: The thromboregulatory and anti-inflammatory potential of human CD39 (hCD39) makes it a gene of interest in xenotransplantation. In porcine endothelium, CD39 activity is generally…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences